Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

zirconium Zr 89-nanocolloidal albumin

A radioimmunoconjugate composed of a nanoformulation of colloidal human serum albumin (HSA) labeled with zirconium Zr 89 (Zr89), via the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine B, with potential imaging activity using positron emission tomography (PET). Upon administration, the zirconium Zr 89-nanocolloidal albumin travels through the bloodstream and into the lymphatic system. Using PET, the draining pattern of the lymph nodes can be visualized and lymph node status, including that of the sentinel lymph node (SLN), can be detected and analyzed. Compared to some other formulations, the smaller particle size of nanocolloidal albumin allows for enhanced imaging of the lymphatic system.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:89-zirconium-Nanocoll
89Zr nanocolloidal albumin
89Zr-colloidal albumin
89Zr-labeled albumin nanocolloid
89Zr-labeled nanocolloid human serum albumin
89Zr-nanocoll
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search